{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:01:44Z","timestamp":1790996504804,"version":"4.1.0"},"reference-count":80,"publisher":"Bentham Science Publishers Ltd.","issue":"14","funder":[{"DOI":"10.13039\/501100001409","name":"Jamia Hamdard, DST FIST","doi-asserted-by":"publisher","award":["SR\/FST\/LS-I\/2018\/151"],"award-info":[{"award-number":["SR\/FST\/LS-I\/2018\/151"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"DST-SERB","doi-asserted-by":"publisher","award":["EMR\/2017\/004400"],"award-info":[{"award-number":["EMR\/2017\/004400"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Coronavirus disease (COVID-19) was reported to be transmitted from bats to humans and, became a pandemic in 2020. COVID-19 is responsible for millions of deaths worldwide and still, the numbers are increasing. Further, despite the availability of vaccines, mutation in the virus continuously poses a threat of re-emergence of the more lethal form of the virus. So far, the repur-posing of drugs has been exercised heavily for the identification of therapeutic agents against COVID-19, which led FDA to approve many drugs for the same e.g., remdesivir, favipiravir, ribavi-rin, etc. The anti-COVID drugs explored via other approaches include nirmatrelvir (used in combi-nation with ritonavir as Paxlovid), tixagevimab and cilgavimab (both used in combination with each other) and others. However, these approved drugs failed to achieve a significant clinical outcome. Globally, natural bioactive have also been explored for anti-COVID-19 effects, based on their tradi-tional medicinal values. Although the clinical findings suggest that FDA-approved drugs and natu-ral bioactives can help reducing the overall mortality rate but the significant clinical outcome was not achieved. Therefore, the focus has been shifted towards new drug development. In line with that, a lot of work has been done and still going on to explore heterocyclic compounds as potent an-ti-COVID-19 drugs. Several heterocyclic scaffolds have been previously reported with potent anti-inflammatory, anticancer, anti-viral, antimicrobial and anti-tubercular effects. Few of them are un-der consideration for clinical trials whereas others are under preclinical investigation. Hence, this review discusses the evidence of rationally designed and tested heterocyclic compounds acting on different targets against COVID-19. The present article will help the researches and will serve as a pivotal resource in the design and development of novel anti-COVID-19 drugs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568026623666230126104156","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T06:54:20Z","timestamp":1674802460000},"page":"1319-1339","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["SAR based Review on Diverse Heterocyclic Compounds with Various\nPotential Molecular Targets in the Fight against COVID-19: A Medicinal\nChemist Perspective"],"prefix":"10.2174","volume":"23","author":[{"given":"Anish","family":"Madan","sequence":"first","affiliation":[{"name":"Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education\n&amp; Research, Jamia Hamdard, New Delhi, 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Garg","sequence":"additional","affiliation":[{"name":"Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education\n&amp; Research, Jamia Hamdard, New Delhi, 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garvit","family":"Satija","sequence":"additional","affiliation":[{"name":"Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education\n&amp; Research, Jamia Hamdard, New Delhi, 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barkha","family":"Sharma","sequence":"additional","affiliation":[{"name":"Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education\n&amp; Research, Jamia Hamdard, New Delhi, 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shaquiquzzaman","sequence":"additional","affiliation":[{"name":"Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education\n&amp; Research, Jamia Hamdard, New Delhi, 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mymoona","family":"Akhter","sequence":"additional","affiliation":[{"name":"Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education\n&amp; Research, Jamia Hamdard, New Delhi, 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashif","family":"Iqubal","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical\nEducation &amp; Research, Jamia Hamdard, New Delhi, 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ahmed","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical\nEducation &amp; Research, Jamia Hamdard, New Delhi, 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhel","family":"Parvez","sequence":"additional","affiliation":[{"name":"Department of Toxicology, School of Chemical\n&amp; Life Sciences, Jamia Hamdard, New Delhi, 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwesha","family":"Das","sequence":"additional","affiliation":[{"name":"Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education\n&amp; Research, Jamia Hamdard, New Delhi, 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khursheed Ahmad","family":"Sheikh","sequence":"additional","affiliation":[{"name":"Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education\n&amp; Research, Jamia Hamdard, New Delhi, 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mumtaz","family":"Alam","sequence":"additional","affiliation":[{"name":"Drug Design and Medicinal Chemistry Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education\n&amp; Research, Jamia Hamdard, New Delhi, 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"100011","DOI":"10.1016\/j.chphi.2021.100011","volume":"2","author":"Jena N.R.","year":"2021","unstructured":"Jena N.R.; Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2. Chem Phys Impact 2021,2,100011","journal-title":"Chem Phys Impact"},{"key":"ref=2","unstructured":"WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data.  (Aug 13, 2022)."},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2174\/1381612827999210111190855","volume":"27","author":"Iqubal A.","year":"2021","unstructured":"Iqubal A.; Iqubal M.K.; Ahmed M.; Haque S.E.; Natural products, a potential therapeutic modality in management and treatment of nCoV-19 infection: Preclinical and clinical based evidence. Curr Pharm Des 2021,27(9),1153-1169","journal-title":"Curr Pharm Des"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/a-1291-7692","volume":"71","author":"Iqubal A.","year":"2021","unstructured":"Iqubal A.; Hoda F.; Najmi A.K.; Haque S.E.; Macrophage activation and cytokine release syndrome in COVID-19: Current updates and analysis of repurposed and investigational anti-cytokine drugs. Drug Res 2021,71(4),173-179","journal-title":"Drug Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/1568026622666220707114121","author":"Ghosh S.","year":"2022","unstructured":"Ghosh S.; Durgvanshi S.; Han S.S.; Bhaskar R.; Sinha J.K.; Therapeutics for the management of cytokine release syndrome in COVID-19. Curr Top Med Chem 2022,22","journal-title":"Curr Top Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3389\/fimmu.2020.00811","volume":"11","author":"Adachi S.","year":"2020","unstructured":"Adachi S.; Koma T.; Doi N.; Nomaguchi M.; Adachi A.; Commentary: Origin and evolution of pathogenic coronaviruses. Front Immunol 2020,11,811","journal-title":"Front Immunol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijbiomac.2021.02.071","volume":"177","author":"Shamsi A.","year":"2021","unstructured":"Shamsi A.; Mohammad T.; Anwar S.; Amani S.; Khan M.S.; Husain F.M.; Rehman M.T.; Islam A.; Hassan M.I.; Potential drug targets of SARS-CoV-2: From genomics to therapeutics. Int J Biol Macromol 2021,177,1-9","journal-title":"Int J Biol Macromol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","volume":"14","author":"Astuti I.","year":"2020","unstructured":"Astuti I.; Ysrafil, ; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr 2020,14(4),407-412","journal-title":"Diabetes Metab Syndr"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10096-020-04138-6","volume":"40","author":"Beyerstedt S.","year":"2021","unstructured":"Beyerstedt S.; Casaro E.B.; Rangel \u00c9.B.; COVID-19: Angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis 2021,40(5),905-919","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"12359","DOI":"10.1021\/acs.jmedchem.0c00606","volume":"63","author":"Gil C.","year":"2020","unstructured":"Gil C.; Ginex T.; Maestro I.; Nozal V.; Barrado-Gil L.; Cuesta-Geijo M.\u00c1.; Urquiza J.; Ram\u00edrez D.; Alonso C.; Campillo N.E.; Martinez A.; COVID-19: Drug targets and potential treatments. J Med Chem 2020,63(21),12359-12386","journal-title":"J Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"113966","DOI":"10.1016\/j.ejmech.2021.113966","volume":"227","author":"Wang Y.T.","year":"2022","unstructured":"Wang Y.T.; Long X.Y.; Ding X.; Fan S.R.; Cai J.Y.; Yang B.J.; Zhang X.F.; Luo R.; Yang L.; Ruan T.; Ren J.; Jing C.X.; Zheng Y.T.; Hao X.J.; Chen D.Z.; Novel nucleocapsid protein-targeting phenanthridine inhibitors of SARS-CoV-2. Eur J Med Chem 2022,227,113966","journal-title":"Eur J Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"129981","DOI":"10.1016\/j.molstruc.2021.129981","volume":"1231","author":"Satyanarayana M.V.","year":"2021","unstructured":"Satyanarayana M.V.; Reddy A.G.; Yedukondalu M.; Tej M.B.; Hossain K.A.; Rao M.V.B.; Pal M.; In silico assessment and sonochemical synthesis of 2-alkynyl 3-chloropyrazines as prospective ligands for SARS-CoV-2. J Mol Struct 2021,1231,129981","journal-title":"J Mol Struct"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"e6469","DOI":"10.1002\/aoc.6469","volume":"36","author":"Nesaragi A.R.","year":"2022","unstructured":"Nesaragi A.R.; Kamble R.R.; Hoolageri S.R.; Mavazzan A.; Madar S.F.; Anand A.; Joshi S.D.; WELPSA: A natural catalyst of alkali and alkaline earth metals for the facile synthesis of tetrahydrobenzo[b]pyrans and pyrano[2,3\u2010d]pyrimidinones as inhibitors of SARS\u2010CoV\u20102. Appl Organomet Chem 2022,36(1),e6469","journal-title":"Appl Organomet Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"113242","DOI":"10.1016\/j.ejmech.2021.113242","volume":"215","author":"Li H.","year":"2021","unstructured":"Li H.; Cheng C.; Li S.; Wu Y.; Liu Z.; Liu M.; Chen J.; Zhong Q.; Zhang X.; Liu S.; Song G.; Discovery and structural optimization of 3-O-\u03b2-chacotriosyl oleanane-type triterpenoids as potent entry inhibitors of SARS-CoV-2 virus infections. Eur J Med Chem 2021,215,113242","journal-title":"Eur J Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1126\/science.abc1560","volume":"368","author":"Yin W.","year":"2020","unstructured":"Yin W.; Mao C.; Luan X.; Shen D.D.; Shen Q.; Su H.; Wang X.; Zhou F.; Zhao W.; Gao M.; Chang S.; Xie Y.C.; Tian G.; Jiang H.W.; Tao S.C.; Shen J.; Jiang Y.; Jiang H.; Xu Y.; Zhang S.; Zhang Y.; Xu H.E.; Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science 2020,368(6498),1499-1504","journal-title":"Science"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.29252\/rbmb.9.1.97","volume":"9","author":"Mostafa-Hedeab G.","year":"2020","unstructured":"Mostafa-Hedeab G.; ACE2 as drug target of COVID-19 virus treatment, simplified updated review. Rep Biochem Mol Biol 2020,9(1),97-105","journal-title":"Rep Biochem Mol Biol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"114121","DOI":"10.1016\/j.ejmech.2022.114121","volume":"231","author":"Sanna V.","year":"2022","unstructured":"Sanna V.; Satta S.; Hsiai T.; Sechi M.; Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition. Eur J Med Chem 2022,231,114121","journal-title":"Eur J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"105272","DOI":"10.1016\/j.bioorg.2021.105272","volume":"116","author":"Mahgoub S.","year":"2021","unstructured":"Mahgoub S.; Kotb El-Sayed M.I.; El-Shehry M.F.; Mohamed Awad S.; Mansour Y.E.; Fatahala S.S.; Synthesis of novel calcium channel blockers with ACE2 inhibition and dual antihypertensive\/anti-inflammatory effects: A possible therapeutic tool for COVID-19. Bioorg Chem 2021,116,105272","journal-title":"Bioorg Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","volume":"253","author":"Elfiky A.A.","year":"2020","unstructured":"Elfiky A.A.; Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci 2020,253,117592","journal-title":"Life Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ijbiomac.2020.12.223","volume":"171","author":"Tiwari V.","year":"2021","unstructured":"Tiwari V.; Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus. Int J Biol Macromol 2021,171,358-365","journal-title":"Int J Biol Macromol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"105209","DOI":"10.1016\/j.antiviral.2021.105209","volume":"196","author":"Zhao J.","year":"2021","unstructured":"Zhao J.; Zhang G.; Zhang Y.; Yi D.; Li Q.; Ma L.; Guo S.; Li X.; Guo F.; Lin R.; Luu G.; Liu Z.; Wang Y.; Cen S.; 2-((1Hindol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors. Antiviral Res 2021,196,105209","journal-title":"Antiviral Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"128741","DOI":"10.1016\/j.molstruc.2020.128741","volume":"1220","author":"Venkateshan M.","year":"2020","unstructured":"Venkateshan M.; Muthu M.; Suresh J.; Ranjith Kumar R.; Azafluorene derivatives as inhibitors of SARS CoV-2 RdRp: Synthesis, physicochemical, quantum chemical, modeling and molecular docking analysis. J Mol Struct 2020,1220,128741","journal-title":"J Mol Struct"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1080\/07391102.2021.1890223","volume":"40","author":"Rajesh K.M.","year":"2022","unstructured":"Rajesh K.M.; Gideon D.A.; Richard M.; Nirusimhan V.; Sherlin R.A.; Edward J.C.; Jeyaraman J.; Dhayabaran V.; In silico evaluation of isatin-based derivatives with RNA-dependent RNA polymerase of the novel coronavirus SARS-CoV-2. J Biomol Struct Dyn 2022,40(15),6710-6724","journal-title":"J Biomol Struct Dyn"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1021\/acsmedchemlett.1c00140","volume":"12","author":"Bobi\u013ceva O.","year":"2021","unstructured":"Bobi\u013ceva O.; Bobrovs R.; Ka\u0146epe I.; Patetko L.; Kalni\u0146\u0161 G.; \u0160i\u0161ovs M.; Bula A.L.; Gr\u0131\u0305nberga S.; Borodu\u0161\u0137is M.; Ramata-Stunda A.; Rostoks N.; Jirgensons A.; Tars K.; Jaudzems K.; Potent SARS-CoV-2 mRNA cap methyltransferase inhibitors by bioisosteric replacement of methionine in SAM cosubstrate. ACS Med Chem Lett 2021,12(7),1102-1107","journal-title":"ACS Med Chem Lett"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/ijp.IJP_115_20","volume":"52","author":"Medhi B.","year":"2020","unstructured":"Medhi B.; Prajapat M.; Sarma P.; Shekhar N.; Avti P.; Sinha S.; Kaur H.; Kumar S.; Bhattacharyya A.; Kumar H.; Bansal S.; Drug for corona virus: A systematic review. Indian J Pharmacol 2020,52(1),56-65","journal-title":"Indian J Pharmacol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"622898","DOI":"10.3389\/fchem.2021.622898","volume":"9","author":"Mengist H.M.","year":"2021","unstructured":"Mengist H.M.; Dilnessa T.; Jin T.; Structural basis of potential inhibitors targeting SARS-CoV-2 main protease. Front Chem 2021,9,622898","journal-title":"Front Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cbpa.2007.07.014","volume":"11","author":"Culhane J.C.","year":"2007","unstructured":"Culhane J.C.; Cole P.A.; LSD1 and the chemistry of histone demethylation. Curr Opin Chem Biol 2007,11(5),561-568","journal-title":"Curr Opin Chem Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1021\/acs.jmedchem.1c00616","volume":"65","author":"Bai B.","year":"2022","unstructured":"Bai B.; Belovodskiy A.; Hena M.; Kandadai A.S.; Joyce M.A.; Saffran H.A.; Shields J.A.; Khan M.B.; Arutyunova E.; Lu J.; Bajwa S.K.; Hockman D.; Fischer C.; Lamer T.; Vuong W.; van Belkum M.J.; Gu Z.; Lin F.; Du Y.; Xu J.; Rahim M.; Young H.S.; Vederas J.C.; Tyrrell D.L.; Lemieux M.J.; Nieman J.A.; Peptidomimetic \u03b1-acyloxymethylketone warheads with six-membered lactam P1 glutamine mimic: SARS-CoV-2 3CL protease inhibition, coronavirus antiviral activity, and in vitro biological stability. J Med Chem 2022,65(4),2905-2925","journal-title":"J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"11267","DOI":"10.1021\/acs.jmedchem.1c00628","volume":"64","author":"Li L.","year":"2021","unstructured":"Li L.; Chenna B.C.; Yang K.S.; Cole T.R.; Goodall Z.T.; Giardini M.; Moghadamchargari Z.; Hernandez E.A.; Gomez J.; Calvet C.M.; Bernatchez J.A.; Mellott D.M.; Zhu J.; Rademacher A.; Thomas D.; Blankenship L.R.; Drelich A.; Laganowsky A.; Tseng C.T.K.; Liu W.R.; Wand A.J.; Cruz-Reyes J.; Siqueira-Neto J.L.; Meek T.D.; Self-masked aldehyde inhibitors: A novel strategy for inhibiting cysteine proteases. J Med Chem 2021,64(15),11267-11287","journal-title":"J Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1021\/acs.jmedchem.1c00665","volume":"65","author":"Konno S.","year":"2022","unstructured":"Konno S.; Kobayashi K.; Senda M.; Funai Y.; Seki Y.; Tamai I.; Sch\u00e4kel L.; Sakata K.; Pillaiyar T.; Taguchi A.; Taniguchi A.; G\u00fctschow M.; M\u00fcller C.E.; Takeuchi K.; Hirohama M.; Kawaguchi A.; Kojima M.; Senda T.; Shirasaka Y.; Kamitani W.; Hayashi Y.; 3CL protease inhibitors with an electrophilic arylketone moiety as anti-SARS-CoV-2 agents. J Med Chem 2022,65(4),2926-2939","journal-title":"J Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"14702","DOI":"10.1021\/acs.jmedchem.1c01214","volume":"64","author":"Ghosh A.K.","year":"2021","unstructured":"Ghosh A.K.; Raghavaiah J.; Shahabi D.; Yadav M.; Anson B.J.; Lendy E.K.; Hattori S.; Higashi-Kuwata N.; Mitsuya H.; Mesecar A.D.; Indole chloropyridinyl ester-derived SARS-CoV-2 3CLpro inhibitors: Enzyme inhibition, antiviral efficacy, structure\u2013activity relationship, and x-ray structural studies. J Med Chem 2021,64(19),14702-14714","journal-title":"J Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.1021\/acs.jmedchem.0c01063","volume":"63","author":"Hoffman R.L.","year":"2020","unstructured":"Hoffman R.L.; Kania R.S.; Brothers M.A.; Davies J.F.; Ferre R.A.; Gajiwala K.S.; He M.; Hogan R.J.; Kozminski K.; Li L.Y.; Lockner J.W.; Lou J.; Marra M.T.; Mitchell L.J.; Murray B.W.; Nieman J.A.; Noell S.; Planken S.P.; Rowe T.; Ryan K.; Smith G.J.; Solowiej J.E.; Steppan C.M.; Taggart B.; Discovery of ketone-based covalent inhibitors of coronavirus 3CL proteases for the potential therapeutic treatment of COVID-19. J Med Chem 2020,63(21),12725-12747","journal-title":"J Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"17366","DOI":"10.1021\/acs.jmedchem.1c01475","volume":"64","author":"Kneller D.W.","year":"2021","unstructured":"Kneller D.W.; Li H.; Galanie S.; Phillips G.; Labb\u00e9 A.; Weiss K.L.; Zhang Q.; Arnould M.A.; Clyde A.; Ma H.; Ramanathan A.; Jonsson C.B.; Head M.S.; Coates L.; Louis J.M.; Bonnesen P.V.; Kovalevsky A.; Structural, electronic, and electrostatic determinants for inhibitor binding to subsites S1 and S2 in SARS-CoV-2 main protease. J Med Chem 2021,64(23),17366-17383","journal-title":"J Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","volume":"63","author":"Zhang L.","year":"2020","unstructured":"Zhang L.; Lin D.; Kusov Y.; Nian Y.; Ma Q.; Wang J.; von Brunn A.; Leyssen P.; Lanko K.; Neyts J.; de Wilde A.; Snijder E.J.; Liu H.; Hilgenfeld R.; \u03b1-ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: Structure-based design, synthesis, and activity assessment. J Med Chem 2020,63(9),4562-4578","journal-title":"J Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ejmech.2019.02.002","volume":"167","author":"Wu R.J.","year":"2019","unstructured":"Wu R.J.; Zhou K.X.; Yang H.; Song G.Q.; Li Y.H.; Fu J.X.; Zhang X.; Yu S.J.; Wang L.Z.; Xiong L.X.; Niu C.W.; Song F.H.; Yang H.; Wang J.G.; Chemical synthesis, crystal structure, versatile evaluation of their biological activities and molecular simulations of novel pyrithiobac derivatives. Eur J Med Chem 2019,167,472-484","journal-title":"Eur J Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"130005","DOI":"10.1016\/j.molstruc.2021.130005","volume":"1232","author":"Douche D.","year":"2021","unstructured":"Douche D.; Sert Y.; Brand\u00e1n S.A.; Kawther A.A.; Bilmez B.; Dege N.; Louzi A.E.; Bougrin K.; Karrouchi K.; Himmi B.; 5-((1H-imidazol-1-yl)methyl)quinolin-8-ol as potential antiviral SARS-CoV-2 candidate: Synthesis, crystal structure, Hirshfeld surface analysis, DFT and molecular docking studies. J Mol Struct 2021,1232,130005","journal-title":"J Mol Struct"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"131020","DOI":"10.1016\/j.molstruc.2021.131020","volume":"1245","author":"Omar A.Z.","year":"2021","unstructured":"Omar A.Z.; Mosa T.M.; El-sadany S.K.; Hamed E.A.; El-atawy M.; Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 protease enzyme: Synthesis and molecular docking study. J Mol Struct 2021,1245,131020","journal-title":"J Mol Struct"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"114030","DOI":"10.1016\/j.ejmech.2021.114030","volume":"228","author":"Zhang J.W.","year":"2022","unstructured":"Zhang J.W.; Xiong Y.; Wang F.; Zhang F.M.; Yang X.; Lin G.Q.; Tian P.; Ge G.; Gao D.; Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19. Eur J Med Chem 2022,228,114030","journal-title":"Eur J Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"114046","DOI":"10.1016\/j.ejmech.2021.114046","volume":"229","author":"Stille J.K.","year":"2022","unstructured":"Stille J.K.; Tjutrins J.; Wang G.; Venegas F.A.; Hennecker C.; Rueda A.M.; Sharon I.; Blaine N.; Miron C.E.; Pinus S.; Labarre A.; Plescia J.; Burai Patrascu M.; Zhang X.; Wahba A.S.; Vlaho D.; Huot M.J.; Schmeing T.M.; Mittermaier A.K.; Moitessier N.; Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors. Eur J Med Chem 2022,229,114046","journal-title":"Eur J Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"131974","DOI":"10.1016\/j.molstruc.2021.131974","volume":"1252","author":"Odabasoglu H.Y.","year":"2022","unstructured":"Odabasoglu H.Y.; Erdogan T.; Karci F.; Synthesis and characterization of heterocyclic disazo - azomethine dyes and investigating their molecular docking and dynamics properties on acetylcholine esterase (AChE), heat shock protein (HSP90\u03b1), nicotinamide Nmethyl transferase (NNMT) and SARS-CoV-2 (2019-nCoV, COVID-19) main protease (Mpro). J Mol Struct 2022,1252,131974","journal-title":"J Mol Struct"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"104497","DOI":"10.1016\/j.bioorg.2020.104497","volume":"106","author":"Dom\u00ednguez-Villa F.X.","year":"2021","unstructured":"Dom\u00ednguez-Villa F.X.; Dur\u00e1n-Iturbide N.A.; \u00c1vila-Z\u00e1rraga J.G.; Synthesis, molecular docking, and in silico ADME\/Tox profiling studies of new 1-aryl-5-(3-azidopropyl)indol-4-ones: Potential inhibitors of SARS CoV-2 main protease. Bioorg Chem 2021,106,104497","journal-title":"Bioorg Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"105363","DOI":"10.1016\/j.bioorg.2021.105363","volume":"116","author":"Al-Wahaibi L.H.","year":"2021","unstructured":"Al-Wahaibi L.H.; Mostafa A.; Mostafa Y.A.; Abou-Ghadir O.F.; Abdelazeem A.H.; Gouda A.M.; Kutkat O.; Abo Shama N.M.; Shehata M.; Gomaa H.A.M.; Abdelrahman M.H.; Mohamed F.A.M.; Gu X.; Ali M.A.; Trembleau L.; Youssif B.G.M.; Discovery of novel oxazole-based macrocycles as anti-coronaviral agents targeting SARS-CoV-2 main protease. Bioorg Chem 2021,116,105363","journal-title":"Bioorg Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"113789","DOI":"10.1016\/j.ejmech.2021.113789","volume":"225","author":"Cui J.","year":"2021","unstructured":"Cui J.; Jia J.; Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors. Eur J Med Chem 2021,225,113789","journal-title":"Eur J Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"132336","DOI":"10.1016\/j.molstruc.2022.132336","volume":"1254","author":"Tahir T.","year":"2022","unstructured":"Tahir T.; Tabassum R.; Javed Q.; Ali A.; Ashfaq M.; Shahzad M.I.; Synthesis, kinetics, structure-activity relationship and in silico ADME studies of new diazenyl azo-phenol derivatives against urease, SARS-CoV-2 main protease (Mpro) and ribosomal protein S1 (RpsA) of Mycobacterium tuberculosis. J Mol Struct 2022,1254,132336","journal-title":"J Mol Struct"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"112702","DOI":"10.1016\/j.ejmech.2020.112702","volume":"206","author":"Liu P.","year":"2020","unstructured":"Liu P.; Liu H.; Sun Q.; Liang H.; Li C.; Deng X.; Liu Y.; Lai L.; Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds. Eur J Med Chem 2020,206,112702","journal-title":"Eur J Med Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"116393","DOI":"10.1016\/j.bmc.2021.116393","volume":"47","author":"Gupta Y.","year":"2021","unstructured":"Gupta Y.; Kumar S.; Zak S.E.; Jones K.A.; Upadhyay C.; Sharma N.; Azizi S.A.; Kathayat R.S.; Poonam, ; Herbert A.S.; Durvasula R.; Dickinson B.C.; Dye J.M.; Rathi B.; Kempaiah P.; Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach. Bioorg Med Chem 2021,47,116393","journal-title":"Bioorg Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.str.2021.06.002","volume":"29","author":"Deshmukh M.G.","year":"2021","unstructured":"Deshmukh M.G.; Ippolito J.A.; Zhang C.H.; Stone E.A.; Reilly R.A.; Miller S.J.; Jorgensen W.L.; Anderson K.S.; Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease. Structure 2021,29(8),823-833.e5","journal-title":"Structure"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"10423","DOI":"10.1002\/anie.202016961","volume":"60","author":"Breidenbach J.","year":"2021","unstructured":"Breidenbach J.; Lemke C.; Pillaiyar T.; Sch\u00e4kel L.; Al Hamwi G.; Diett M.; Gedschold R.; Geiger N.; Lopez V.; Mirza S.; Namasivayam V.; Schiedel A.C.; Sylvester K.; Thimm D.; Vielmuth C.; Phuong Vu L.; Zyulina M.; Bodem J.; G\u00fctschow M.; M\u00fcller C.E.; Targeting the main protease of SARS\u2010CoV\u20102: From the establishment of high throughput screening to the design of tailored inhibitors. Angew Chem Int Ed 2021,60(18),10423-10429","journal-title":"Angew Chem Int Ed"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/bio.4098","volume":"36","author":"Singhal S.","year":"2021","unstructured":"Singhal S.; Khanna P.; Khanna L.; Synthesis, comparative in vitro antibacterial, antioxidant and UV fluorescence studies of bis indole Schiff bases and molecular docking with ct\u2010DNA and SARS\u2010CoV\u20102 Mpro. Luminescence 2021,36(6),1531-1543","journal-title":"Luminescence"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1080\/07391102.2021.1905549","volume":"40","author":"Khorsandi Z.","year":"2022","unstructured":"Khorsandi Z.; Afshinpour M.; Molaei F.; Askandar R.H.; Keshavarzipour F.; Abbasi M.; Sadeghi-Aliabadi H.; Design and synthesis of novel Phe-Phe hydroxyethylene derivatives as potential coronavirus main protease inhibitors. J Biomol Struct Dyn 2022,40(17),7940-7948","journal-title":"J Biomol Struct Dyn"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1021\/acscentsci.1c00039","volume":"7","author":"Zhang C.H.","year":"2021","unstructured":"Zhang C.H.; Stone E.A.; Deshmukh M.; Ippolito J.A.; Ghahremanpour M.M.; Tirado-Rives J.; Spasov K.A.; Zhang S.; Takeo Y.; Kudalkar S.N.; Liang Z.; Isaacs F.; Lindenbach B.; Miller S.J.; Anderson K.S.; Jorgensen W.L.; Potent noncovalent inhibitors of the main protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations. ACS Cent Sci 2021,7(3),467-475","journal-title":"ACS Cent Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1021\/acsmedchemlett.0c00521","volume":"11","author":"Ghahremanpour M.M.","year":"2020","unstructured":"Ghahremanpour M.M.; Tirado-Rives J.; Deshmukh M.; Ippolito J.A.; Zhang C-H.; de Vaca I.C.; Liosi M-E.; Anderson K.S.; Jorgensen W.L.; Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2. ACS Med Chem Lett 2020,11(12),2526-2533","journal-title":"ACS Med Chem Lett"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1039\/D1MD00247C","volume":"12","author":"Bai B.","year":"2021","unstructured":"Bai B.; Arutyunova E.; Khan M.B.; Lu J.; Joyce M.A.; Saffran H.A.; Shields J.A.; Kandadai A.S.; Belovodskiy A.; Hena M.; Vuong W.; Lamer T.; Young H.S.; Vederas J.C.; Tyrrell D.L.; Lemieux M.J.; Nieman J.A.; Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors. RSC Med Chem 2021,12(10),1722-1730","journal-title":"RSC Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"10045","DOI":"10.1080\/07391102.2021.1938230","volume":"40","author":"Karagoz Gen\u00e7 Z.","year":"2022","unstructured":"Karagoz Gen\u00e7 Z.; Gen\u00e7 M.; \u00c7o\u015fut B.; Turgut M.; The novel tetrahydropyrimidine derivative as inhibitor of SARS CoV-2: Synthesis, modeling and molecular docking analysis. J Biomol Struct Dyn 2022,40(20),10045-10056","journal-title":"J Biomol Struct Dyn"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1021\/acs.jmedchem.0c02258","volume":"65","author":"Dai W.","year":"2022","unstructured":"Dai W.; Jochmans D.; Xie H.; Yang H.; Li J.; Su H.; Chang D.; Wang J.; Peng J.; Zhu L.; Nian Y.; Hilgenfeld R.; Jiang H.; Chen K.; Zhang L.; Xu Y.; Neyts J.; Liu H.; Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-CoV-2. J Med Chem 2022,65(4),2794-2808","journal-title":"J Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1021\/acs.jmedchem.1c00509","volume":"65","author":"Kitamura N.","year":"2022","unstructured":"Kitamura N.; Sacco M.D.; Ma C.; Hu Y.; Townsend J.A.; Meng X.; Zhang F.; Zhang X.; Ba M.; Szeto T.; Kukuljac A.; Marty M.T.; Schultz D.; Cherry S.; Xiang Y.; Chen Y.; Wang J.; Expedited approach toward the rational design of noncovalent SARS-CoV-2 main protease inhibitors. J Med Chem 2022,65(4),2848-2865","journal-title":"J Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1021\/acs.jmedchem.1c02022","volume":"65","author":"Liu N.","year":"2022","unstructured":"Liu N.; Zhang Y.; Lei Y.; Wang R.; Zhan M.; Liu J.; An Y.; Zhou Y.; Zhan J.; Yin F.; Li Z.; Design and evaluation of a novel peptide\u2013drug conjugate covalently targeting SARS-CoV-2 papain-like protease. J Med Chem 2022,65(1),876-884","journal-title":"J Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/cmdc.202000548","volume":"16","author":"Welker A.","year":"2021","unstructured":"Welker A.; Kersten C.; M\u00fcller C.; Madhugiri R.; Zimmer C.; M\u00fcller P.; Zimmermann R.; Hammerschmidt S.; Maus H.; Ziebuhr J.; Sotriffer C.; Schirmeister T.; Structure\u2010activity relationships of benzamides and isoindolines designed as SARS\u2010CoV protease inhibitors effective against SARS\u2010CoV\u20102. ChemMedChem 2021,16(2),340-354","journal-title":"ChemMedChem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.chembiol.2021.04.020","volume":"28","author":"Shan H.","year":"2021","unstructured":"Shan H.; Liu J.; Shen J.; Dai J.; Xu G.; Lu K.; Han C.; Wang Y.; Xu X.; Tong Y.; Xiang H.; Ai Z.; Zhuang G.; Hu J.; Zhang Z.; Li Y.; Pan L.; Tan L.; Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2. Cell Chem Biol 2021,28(6),855-865.e9","journal-title":"Cell Chem Biol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1021\/acs.jmedchem.1c01307","volume":"65","author":"Shen Z.","year":"2022","unstructured":"Shen Z.; Ratia K.; Cooper L.; Kong D.; Lee H.; Kwon Y.; Li Y.; Alqarni S.; Huang F.; Dubrovskyi O.; Rong L.; Thatcher G.R.J.; Xiong R.; Design of SARS-CoV-2 PLpro inhibitors for COVID-19 antiviral therapy leveraging binding cooperativity. J Med Chem 2022,65(4),2940-2955","journal-title":"J Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"FDD42","DOI":"10.4155\/fdd-2020-0012","volume":"2","author":"Senanayake S.L.","year":"2020","unstructured":"Senanayake S.L.; Overcoming nonstructural protein 15-nidoviral uridylate-specific endoribonuclease (NSP15\/NendoU) activity of SARS-CoV-2. Future Drug Discov 2020,2(3),FDD42","journal-title":"Future Drug Discov"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/pathogens11010094","volume":"11","author":"Leung A.K.L.","year":"2022","unstructured":"Leung A.K.L.; Griffin D.E.; Bosch J.; Fehr A.R.; The conserved macrodomain is a potential therapeutic target for coronaviruses and alphaviruses. Pathogens 2022,11(1),94","journal-title":"Pathogens"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pbiomolbio.2021.02.002","volume":"163","author":"Brosey C.A.","year":"2021","unstructured":"Brosey C.A.; Houl J.H.; Katsonis P.; Balapiti-Modarage L.P.F.; Bommagani S.; Arvai A.; Moiani D.; Bacolla A.; Link T.; Warden L.S.; Lichtarge O.; Jones D.E.; Ahmed Z.; Tainer J.A.; Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors. Prog Biophys Mol Biol 2021,163,171-186","journal-title":"Prog Biophys Mol Biol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1080\/14787210.2021.1893692","volume":"19","author":"Iqubal A.","year":"2021","unstructured":"Iqubal A.; Iqubal M.K.; Hoda F.; Najmi A.K.; Haque S.E.; COVID-19 and cardiovascular complications: An update from the underlying mechanism to consequences and possible clinical intervention. Expert Rev Anti Infect Ther 2021,19(9),1083-1092","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1039\/D1MD00202C","volume":"12","author":"Kumar S.","year":"2021","unstructured":"Kumar S.; Gupta Y.; Zak S.E.; Upadhyay C.; Sharma N.; Herbert A.S.; Durvasula R.; Potemkin V.; Dye J.M.; A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU\/NSP15): In silico and in vitro investigations. RSC Med Chem 2021,12,1757-1764","journal-title":"RSC Med Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"e0255335","DOI":"10.1371\/journal.pone.0255335","volume":"16","author":"Ricke-Hoch M.","year":"2021","unstructured":"Ricke-Hoch M.; Stelling E.; Lasswitz L.; Gunesch A.P.; Kasten M.; Zapatero-Belinch\u00f3n F.J.; Brogden G.; Gerold G.; Pietschmann T.; Montiel V.; Balligand J.L.; Facciotti F.; Hirsch E.; Gausepohl T.; Elbahesh H.; Rimmelzwaan G.F.; H\u00f6fer A.; K\u00fchnel M.P.; Jonigk D.; Eigendorf J.; Tegtbur U.; Mink L.; Scherr M.; Illig T.; Schambach A.; Pfeffer T.J.; Hilfiker A.; Haverich A.; Hilfiker-Kleiner D.; Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS One 2021,16(8),e0255335","journal-title":"PLoS One"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"113814","DOI":"10.1016\/j.ejmech.2021.113814","volume":"226","author":"Desantis J.","year":"2021","unstructured":"Desantis J.; Mercorelli B.; Celegato M.; Croci F.; Bazzacco A.; Baroni M.; Siragusa L.; Cruciani G.; Loregian A.; Goracci L.; Indomethacin-based PROTACs as pan-coronavirus antiviral agents. Eur J Med Chem 2021,226,113814","journal-title":"Eur J Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"131782","DOI":"10.1016\/j.molstruc.2021.131782","volume":"1250","author":"Haribabu J.","year":"2022","unstructured":"Haribabu J.; Garisetti V.; Malekshah R.E.; Srividya S.; Gayathri D.; Bhuvanesh N.; Mangalaraja R.V.; Echeverria C.; Karvembu R.; Design and synthesis of heterocyclic azole based bioactive compounds: Molecular structures, quantum simulation, and mechanistic studies through docking as multi-target inhibitors of SARS-CoV-2 and cytotoxicity. J Mol Struct 2022,1250,131782","journal-title":"J Mol Struct"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"116523","DOI":"10.1016\/j.bmc.2021.116523","volume":"53","author":"Ni Y.","year":"2022","unstructured":"Ni Y.; Liao J.; Qian Z.; Wu C.; Zhang X.; Zhang J.; Xie Y.; Jiang S.; Synthesis and evaluation of enantiomers of hydroxychloroquine against SARS-CoV-2 in vitro. Bioorg Med Chem 2022,53,116523","journal-title":"Bioorg Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"130665","DOI":"10.1016\/j.molstruc.2021.130665","volume":"1241","author":"Obakachi V.A.","year":"2021","unstructured":"Obakachi V.A.; Kushwaha N.D.; Kushwaha B.; Mahlalela M.C.; Shinde S.R.; Kehinde I.; Karpoormath R.; Design and synthesis of pyrazolone-based compounds as potent blockers of SARS-CoV-2 viral entry into the host cells. J Mol Struct 2021,1241,130665","journal-title":"J Mol Struct"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"113863","DOI":"10.1016\/j.ejmech.2021.113863","volume":"226","author":"Di Sarno V.","year":"2021","unstructured":"Di Sarno V.; Lauro G.; Musella S.; Ciaglia T.; Vestuto V.; Sala M.; Scala M.C.; Smaldone G.; Di Matteo F.; Novi S.; Tecce M.F.; Moltedo O.; Bifulco G.; Campiglia P.; Gomez-Monterrey I.M.; Snoeck R.; Andrei G.; Ostacolo C.; Bertamino A.; Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization. Eur J Med Chem 2021,226,113863","journal-title":"Eur J Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.dcmed.2021.06.004","volume":"4","author":"Khan S.","year":"2021","unstructured":"Khan S.; Kale M.; Siddiqui F.; Nema N.; Novel pyrimidine-benzimidazole hybrids with antibacterial and antifungal properties and potential inhibition of SARS-CoV-2 main protease and spike glycoprotein. Digit Chinese Med 2021,4(2),102-119","journal-title":"Digit Chinese Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"132010","DOI":"10.1016\/j.molstruc.2021.132010","volume":"1251","author":"Khalil T.E.","year":"2022","unstructured":"Khalil T.E.; Elbadawy H.A.; Attia A.A.; El-Sayed D.S.; Synthesis, spectroscopic, and computational studies on molecular charge-transfer complex of 2-((2-hydroxybenzylidene) amino)-2-(hydroxymethyl) propane-1, 3-diol with chloranilic acid: Potential antiviral activity simulation of CT-complex against SARS-CoV-2. J Mol Struct 2022,1251,132010","journal-title":"J Mol Struct"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"130480","DOI":"10.1016\/j.molstruc.2021.130480","volume":"1239","author":"Benbouguerra K.","year":"2021","unstructured":"Benbouguerra K.; Chafai N.; Chafaa S.; Touahria Y.I.; Tlidjane H.; New \u03b1-Hydrazinophosphonic acid: Synthesis, characterization, DFT study and in silico prediction of its potential inhibition of SARS-CoV-2 main protease. J Mol Struct 2021,1239,130480","journal-title":"J Mol Struct"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"105196","DOI":"10.1016\/j.bioorg.2021.105196","volume":"115","author":"Wang K.","year":"2021","unstructured":"Wang K.; Wu J.J.; Xin-Zhang, ; Zeng Q.X.; Zhang N.; Huang W.J.; Tang S.; Wang Y.X.; Kong W.J.; Wang Y.C.; Li Y.H.; Song D.Q.; Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage. Bioorg Chem 2021,115,105196","journal-title":"Bioorg Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/cplu.202100133","volume":"86","author":"Su\u00e1rez M.","year":"2021","unstructured":"Su\u00e1rez M.; Makowski K.; Lemos R.; Almagro L.; Rodr\u00edguez H.; Herranz M.\u00c1.; Molero D.; Ortiz O.; Maroto E.; Albericio F.; Murata Y.; Mart\u00edn N.; An androsterone\u2010H2@C60 hybrid: Synthesis, properties and molecular docking simulations with SARS\u2010Cov\u20102. ChemPlusChem 2021,86(7),970-971","journal-title":"ChemPlusChem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"17777","DOI":"10.1039\/D1NJ02955J","volume":"45","author":"Linet A.","year":"2021","unstructured":"Linet A.; Joseph M.M.; Haritha M.; Shamna K.; Varughese S.; Devi P.S.; Suresh C.H.; Maiti K.K.; Neogi I.; De novo design and synthesis of boomerang-shaped molecules and their in silico and SERS-based interactions with SARS-CoV-2 spike protein and ACE2. New J Chem 2021,45(38),17777-17781","journal-title":"New J Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"e14846","DOI":"10.1111\/ijcp.14846","volume":"75","author":"Duran N.","year":"2021","unstructured":"Duran N.; Polat M.F.; Aktas D.A.; Alagoz M.A.; Ay E.; Cimen F.; Tek E.; Anil B.; Burmaoglu S.; Algul O.; New chalcone derivatives as effective against SARS\u2010CoV\u20102 agent. Int J Clin Pract 2021,75(12),e14846","journal-title":"Int J Clin Pract"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1021\/acs.jmedchem.0c01929","volume":"65","author":"Li Y.","year":"2022","unstructured":"Li Y.; Cao L.; Li G.; Cong F.; Li Y.; Sun J.; Luo Y.; Chen G.; Li G.; Wang P.; Xing F.; Ji Y.; Zhao J.; Zhang Y.; Guo D.; Zhang X.; Remdesivir metabolite GS-441524 effectively inhibits SARS-CoV-2 infection in mouse models. J Med Chem 2022,65(4),2785-2793","journal-title":"J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"105131","DOI":"10.1016\/j.bioorg.2021.105131","volume":"114","author":"Girgis A.S.","year":"2021","unstructured":"Girgis A.S.; Panda S.S.; Srour A.M.; Abdelnaser A.; Nasr S.; Moatasim Y.; Kutkat O.; El Taweel A.; Kandeil A.; Mostafa A.; Ali M.A.; Fawzy N.G.; Bekheit M.S.; Shalaby E.M.; Gigli L.; Fayad W.; Soliman A.A.F.; 3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2. Bioorg Chem 2021,114,105131","journal-title":"Bioorg Chem"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026623666230126104156","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/213171\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026623666230126104156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T09:19:31Z","timestamp":1694078371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/213171\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":80,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026623666230126104156","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}